Quanzhou Duohou Trading Co., Ltd. – Trademark Portfolio
Entity Type: 99
Quanzhou Duohou Trading Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include COMASUA, GIWYTEY, FIEPORDS, and SESFINYKI. The owner is based in Quanzhou, Fujian.
Chifeng Rd., Chidian Town, Jinjiang
701, Stairway 3, Block 5, No. 861
Quanzhou, Fujian 362212 , CN
Showing of trademarks Trademarks
Trademark Classifications
Quanzhou Duohou Trading Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Quanzhou Duohou Trading Co., Ltd. have?
Quanzhou Duohou Trading Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Quanzhou Duohou Trading Co., Ltd. file in?
Quanzhou Duohou Trading Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Quanzhou Duohou Trading Co., Ltd.'s most well-known trademarks?
Quanzhou Duohou Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as COMASUA, GIWYTEY, FIEPORDS, and SESFINYKI. These are among 4 currently registered trademarks in the portfolio.
What is Quanzhou Duohou Trading Co., Ltd.'s trademark registration success rate?
Quanzhou Duohou Trading Co., Ltd. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.